Advances in Delaying the Onset of Type 1 Diabetes: What Do You Need to Know Now and in the Future?
(11)
Image For Activity Cover
Availability
On-Demand
Expires on Dec 31, 2024
Cost
$0.00
Credit Offered
1.5 AMA PRA Category 1 Credits
1.5 ABIM-MOC Points
1.5 Participation Credits
  • Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
  • Recommended

 A deep dive on the immunologic aspects of Type 1 Diabetes (T1D) and how these can be utilized to delay onset of T1D. Topics will include applications of immunologic principles to prevent T1D, the latest advances in screening for T1D, and how to utilize immunotherapies to delay T1D.

Pediatric endocrinology team members, including physicians, advance practice providers (NPs, PAs), nurses, adult endocrinologists, diabetologists, Certified Diabetes Educators, primary care providers, and others who manage patients with T1D.
  • Describe immunotherapeutic approaches to delaying clinical T1D to patients and families.
  • Advise clinical colleagues on the appropriate screening for T1D in their patients.
  • Utilize approved immunotherapy to delay onset of T1D.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society, The France Foundation, DocMatter. 

AMA PRA Category 1 Credit

The Endocrine Society designates this course for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.


Maintenance of Certification (MOC)
Successful completion of this course, which includes participation in the evaluation component, enables the participant to earn up to 1.50 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Linda DiMeglio, MD, MPH – Program Chair
Indiana University School of Medicine
Indianapolis, IN

Riitta Veijola, MD, PhD
Oulu University Hospital
Oulu, Finland

Aniket Sidhaye, MD
Johns Hopkins University
Baltimore, MD

Marian Rewers, MD, PhD
University of Colorado School of Medicine
Aurora, CO

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

  • Linda DiMeglio, MD, MPH: Dompe – Research Support; Lilly – Research Support, Data Safety Monitoring Board; Mannkind – Research Support; Medtronic – Research Support; Provention – Research Support; Zealand – Research Support; Merck – Consultant; Vertex – Consultant; Abata -  Consultant
  • Marian Rewers, MD, PhD: Sanofi - Consultant, Advisory Board; Proventio Bio – Educational Grant; Jenssen R&D – Consultant; Medscape – Advisory Board

The following faculty reported no relevant financial relationships:
 Riitta Veijola, MD, PhD
Aniket Sidhaye, MD

The following committee member who planned and reviewed content for this activity reported relevant financial relationships: 
Savitha Subramanian, MD: Abbott Diabetes Care; Advisory board member; Amarin, advisory board, American Board of Internal Medicine, Exam Committee member

The Endocrine Society and The France Foundation staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

This educational activity is supported by an educational grant from Provention Bio .
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By